Diversity is now a key priority for the life sciences industry and regulators, but in today’s increasingly complex clinical trial landscape, enrolling patients has become more challenging than ever. This session will highlight how sponsors and CROs can leverage site-level performance metrics and enrolled patient demographics from over 28,000 clinical trials combined into a single view to not only drive significant progress with trial timelines but also meet diversity goals.

Mobile health has a significant impact on patient retention and experience in clinical trials. However,it’s still under-utilized as there is a perception that more complex assessments and procedures cannot be conducted effectively in the home. This case study highlights how mdgroup worked with a client to implement complex sample collections in the homes of patients suffering from a rare disease, resulting in reduced travel burden and low dropout rates.

We would like to invite you to join us for an informative event about overcoming obstacles in recruiting patients for BioPharma clinical trials. During this event, we will delve into barriers such as lack of awareness and financial considerations that can impede clinical trial recruitment success. Additionally, impactful strategies to increase clinical trial participation and recruitment success will be shared.

In a clinical research landscape crowded with technology systems, how can you achieve meaningful efficiency and speed during study startup? Explore 5 critical integrations between technology systems in place at your organization, within your research sites, and across the IRB that can significantly improve your activation timelines. 

Inflationary pressures and resource constraints are putting study timelines and budgets at risk, frustrating sites and sponsors alike.

In this session, we’ll introduce Good Feasibility Practices as the only way to build healthy long-term sponsor-site relationships: 

• Start early in the planning phase
• Use feasibility assessments to gain mutual understanding and respect
• Develop a company-wide feasibility program that captures and connects feasibility assessments at the portfolio, study, and site level

Our industry is challenged to find the right resources to drive operational best practice. There is also an expectation to move at the “speed of Covid” for every trial. It feels like an either/or. However, you can have both. You can accelerate timelines with fewer resources. Join this exciting session to learn about: The biggest time and resource drains on clinical trials; Applying AI/ML to improve efficiency; Challenging your own internal processes to get to market faster.

As the global Life Sciences industry modernizes its’ approach to clinical trials, we’ve seen incredible growth in clinical study technology. Activating sites and granting them access to your systems can be time consuming often delaying study timelines. Come learn how Exostar transforms access management by providing a connected ecosystem of sites, CROs and sponsors which expedites timelines while enabling frictionless access for sites and users. 

Research sites are an essential partner in achieving your research goals, but due to staffing shortages, increasingly complex protocols, and duplicative technology, site challenges are at an all time high. Learn 5 different approaches to improving how you work with your research sites, informed by Advarra’s research site community.

No matter what method is used, the goal of informed consent remains the same – to properly inform patients as efficiently and effectively as possible. In this session, we’ll explore how to use technology to improve the consent experience for sites as well as participants, regardless of whether it’s in the clinic, living room, or both.